Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive iTBS for First-Episode Schizophrenia
NCT07116850Completed
- Sponsor
- The First Hospital of Hebei Medical University
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by The First Hospital of Hebei Medical University. Primary endpoint: Total Effective Rate based on Positive and Negative Syndrome Scale at 3 months. Started Jan 2024; status: completed.
Beyond the preview
Go deeper on NCT07116850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116850.